Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

SEC Filing · EFFECT

ZYNEX INC

SEC Filing

Filed Mar 18, 2026Accepted Mar 18, 2026, 8:15 PM EDTCIK 846475Accession 9999999995-26-000842
Share

Company context

Zynex, founded in 1996, is a pain management device manufacturer and distributor. For additional information, visit: www.zynex.com.

Historical securities (2)

Recent company filings

  1. Entry into a Material Definitive Agreement · Termination of a Material Definitive Agreement · Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement · Unregistered Sales of Equity Securities · Material Modification to Rights of Security Holders · Changes in Control of Registrant · Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements · Amendments to Articles of Incorporation or Bylaws; Change in Fiscal YearMar 26, 2026
  2. 15-12G filingMar 26, 2026
  3. S-8 POS filingMar 26, 2026
  4. S-8 POS filingMar 26, 2026
  5. Bankruptcy or ReceivershipMar 20, 2026

As-filed source

Primary evidence